Literature DB >> 21159761

Phantom vibration syndrome among medical staff: a cross sectional survey.

Michael B Rothberg1, Ashish Arora, Jodie Hermann, Reva Kleppel, Peter St Marie, Paul Visintainer.   

Abstract

OBJECTIVE: To describe the prevalence of and risk factors for experiencing "phantom vibrations," the sensory hallucination sometimes experienced by people carrying pagers or cell phones when the device is not vibrating.
DESIGN: Cross sectional survey.
SETTING: Academic medical centre. PARTICIPANTS: 176 medical staff who responded to questionnaire (76% of the 232 people invited). Measurements Electronic survey consisting of 17 questions about demographics, device use, phantom vibrations experienced, and attempts to stop them.
RESULTS: Of the 169 participants who answered the question, 115 (68%, 95% confidence interval 61% to 75%) reported having experienced phantom vibrations. Most (68/112) who experienced phantom vibrations did so after carrying the device between 1 month and 1 year, and 13% experienced them daily. Four factors were independently associated with phantom vibrations: occupation (resident v attending physician, prevalence ratio 1.47, 95% confidence interval 1.10 to 1.97), device location (breast pocket v belt, prevalence ratio 1.66, 1.29 to 2.14), hours carried (per 6 hour increment, prevalence ratio 1.30, 1.07 to 1.58), and more frequent use in vibrate mode (per frequency category, prevalence ratio 1.18, 1.03 to 1.34). Of those who experienced phantom vibrations, 43 (39%, 30% to 48%) were able to stop them. Strategies for stopping phantom vibrations included taking the device off vibrate mode, changing the location of the device, and using a different device (success rates 75% v 63% v 50%, respectively, P=0.217). However, 39% (30% to 49%) of respondents did not attempt any strategies.
CONCLUSIONS: Phantom vibration syndrome is common among those who use electronic devices.

Entities:  

Mesh:

Year:  2010        PMID: 21159761     DOI: 10.1136/bmj.c6914

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  7 in total

1.  A Perceptual Inference Mechanism for Hallucinations Linked to Striatal Dopamine.

Authors:  Clifford M Cassidy; Peter D Balsam; Jodi J Weinstein; Rachel J Rosengard; Mark Slifstein; Nathaniel D Daw; Anissa Abi-Dargham; Guillermo Horga
Journal:  Curr Biol       Date:  2018-02-02       Impact factor: 10.834

2.  Guided by Voices: Hallucinations and the Psychosis Spectrum.

Authors:  Albert R Powers; Philip R Corlett; David A Ross
Journal:  Biol Psychiatry       Date:  2018-09-15       Impact factor: 13.382

3.  Possible association between phantom vibration syndrome and occupational burnout.

Authors:  Chao-Pen Chen; Chi-Cheng Wu; Li-Ren Chang; Yu-Hsuan Lin
Journal:  Neuropsychiatr Dis Treat       Date:  2014-12-04       Impact factor: 2.570

4.  Prevalence and Pattern of Phantom Ringing and Phantom Vibration among Medical Interns and their Relationship with Smartphone Use and Perceived Stress.

Authors:  Ajish G Mangot; Vasantmeghna S Murthy; Sharad V Kshirsagar; Ajay H Deshmukh; Dinesh V Tembe
Journal:  Indian J Psychol Med       Date:  2018 Sep-Oct

5.  Investigation of the Role of Anxiety and Depression on the Formation of Phantom Vibration and Ringing Syndrome Caused by Working Stress during Medical Internship.

Authors:  Yu-Hsuan Lin; Kuan-I Lin; Yuan-Chien Pan; Sheng-Hsuan Lin
Journal:  Int J Environ Res Public Health       Date:  2020-10-14       Impact factor: 3.390

6.  Prevalent hallucinations during medical internships: phantom vibration and ringing syndromes.

Authors:  Yu-Hsuan Lin; Sheng-Hsuan Lin; Peng Li; Wei-Lieh Huang; Ching-Yen Chen
Journal:  PLoS One       Date:  2013-06-10       Impact factor: 3.240

7.  Phantom Phone Signals in youths: Prevalence, correlates and relation to psychopathology.

Authors:  Simone Pisano; Pietro Muratori; Vincenzo Paolo Senese; Chiara Gorga; Margherita Siciliano; Marco Carotenuto; Raffaella Iuliano; Carmela Bravaccio; Simona Signoriello; Antonella Gritti; Antonio Pascotto; Gennaro Catone
Journal:  PLoS One       Date:  2019-01-04       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.